Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
about
Diabetes Care: Inspiration from Sikhism.Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients.SGLT2 inhibitor/DPP-4 inhibitor combination therapy - complementary mechanisms of action for management of type 2 diabetes mellitus.Translating diabetes research from multiple directions - microvascular to psychosocialEducation and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment.Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.Associations between having an informal caregiver, social support, and self-care among low-income adults with poorly controlled diabetes.Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).Premorbid risk perception, lifestyle, adherence and coping strategies of people with diabetes mellitus: A phenomenological study in the Brong Ahafo Region of Ghana.Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: What should be the targets for future research?Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review
P2860
Q30234334-19BB9F0C-CC34-4B27-9BE8-78BB6A40E140Q37737463-402FB529-12D4-408D-8046-CBEB2D865A38Q38633143-E6EF3200-D9A2-462A-84FA-13565A7ECD1CQ39189383-04698561-FD00-4D30-B339-09A7F8C76639Q42656616-F0D9C862-07DA-493B-AA4B-AA307BE99685Q42701527-45AAEEA9-829A-4035-B6B7-76C66CC416DAQ46519581-8814EFEF-94D1-4876-B4A8-E039F49C7B29Q47621142-F6C0FE63-82BB-4B46-9B39-B9BC39DAC1E8Q51744128-4BFC2543-F088-472C-A087-D5F45FA0FEADQ55041856-B86E94FC-006C-49F9-8105-C2B058FAFF71Q55265965-450A4E64-42A9-4080-8281-D7726ACABCB7Q57817716-1E4AFE60-1164-46EC-89E8-636CDC4AFDB1Q58099964-366EC041-FC66-42B9-81FE-8768C2675AA4
P2860
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Poor medication adherence in t ...... oblem and its key contributors
@ast
Poor medication adherence in t ...... oblem and its key contributors
@en
Poor medication adherence in t ...... oblem and its key contributors
@nl
type
label
Poor medication adherence in t ...... oblem and its key contributors
@ast
Poor medication adherence in t ...... oblem and its key contributors
@en
Poor medication adherence in t ...... oblem and its key contributors
@nl
prefLabel
Poor medication adherence in t ...... oblem and its key contributors
@ast
Poor medication adherence in t ...... oblem and its key contributors
@en
Poor medication adherence in t ...... oblem and its key contributors
@nl
P2860
P3181
P356
P1476
Poor medication adherence in t ...... oblem and its key contributors
@en
P2093
Robert R Henry
William H Polonsky
P2860
P304
P3181
P356
10.2147/PPA.S106821
P407
P577
2016-01-01T00:00:00Z